Acurx Pharmaceuticals, INC. (ACXP) — 424B5 Filings
All 424B5 filings from Acurx Pharmaceuticals, INC.. Browse 1 424B5 reports with AI-powered summaries and risk analysis.
424B5 Filings (1)
-
Acurx Pharmaceuticals Files Prospectus Supplement
— Apr 16, 2026 Risk: medium
Acurx Pharmaceuticals, Inc. filed a 424B5 prospectus supplement on April 16, 2026, related to its previously filed registration statement. This filing pertains
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX